• Technology Application Deep Dive
    Nov. 05, 2025

    Global demand for pharma outsourcing is rising to meet the demands of pharma/biopharma industry. Advances in analytics, Manufacturing 5.0, and emerging therapeutic modalities are reshaping how outsourcing operates. The market is shifting from traditional, specialized service…
  • State of the Market
    April 27, 2026

    This report analyzes the transformation in outsourced sales from fragmented, activity-led execution to integrated, outcome-driven revenue systems. It highlights how enterprises are shifting toward pipeline-backed growth, AI-enabled decisioning, and tighter alignment across sales, marketing, and operations.…
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • PEAK Matrix®
    Nov. 04, 2025

    Outsourced sales services are entering a new phase as AI and elevated buyer expectations reshape how pipelines are built and revenue is sustained. Providers are moving from fragmented toolsets to connected systems that integrate forecasting, lead…
  • Category Strategy Templates
    Oct. 17, 2025

    Procurement organizations prioritize reducing costs, managing risks, and creating business value. Category management helps achieve these goals by optimizing category spend, identifying cost-saving opportunities, and improving operational efficiency. In the face of emerging agentic AI use…
  • State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • State of the Market
    April 09, 2026

    Enterprises are increasingly moving beyond fragmented automation deployments toward unified platforms that enable enterprise-wide transformation. Intelligent Process Automation Platforms (IPAP) integrate rules-based automation, AI-driven technologies such as IDP, generative AI, and agentic AI, along with orchestration…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Discovery
    March 19, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world’s leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Technology Awareness Deep Dive
    Dec. 30, 2025

    The global rise in aging population creates a need for several strategies to manage age-associated diseases, health challenges, extend longevity, and increase quality of life. As we understand the science of aging and the interconnections of…
  • Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • Provider Compendium
    April 27, 2026

    Agentic AI platforms enable enterprises to design and govern autonomous AI agents that can interpret high-level business objectives and execute complex, cross-system workflows. These platforms support goal-driven reasoning, multi-step task orchestration, and adaptive decision-making in response…
  • PEAK Matrix®
    Dec. 10, 2025

    The Payments IT services market is undergoing a significant transformation. For years, enterprises focused on compliance, scheme-specific upgrades, and incremental improvements to legacy platforms. That approach is no longer sufficient. Rising transaction volumes, real-time expectations, interoperability…
  • Technology Application Deep Dive
    April 23, 2026

    Digital Therapeutics (DTx) represent a rapidly evolving class of evidence-based interventions that leverage software as a medical device to prevent, manage, or treat medical conditions through behavioral modification, personalized feedback, and continuous data-driven support. Unlike general…
  • PEAK Matrix®
    July 31, 2025

    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments,…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • PEAK Matrix®
    Nov. 13, 2025

    As cloud costs grow more dynamic and AI use proliferates, FinOps is evolving from cost reporting to a broader operating model that blends granular cost/usage analytics with governance and policy management, AI-powered automation, sustainability/carbon tracking, and…
  • PEAK Matrix®
    Sep. 12, 2025

    As enterprises accelerate digital transformation, low-code application development platforms are playing an increasingly strategic role in enabling organizations to quickly build engaging, intuitive, and personalized applications. Unlike traditional development approaches, low-code solutions empower businesses to enhance…
  • PEAK Matrix®
    Sep. 01, 2025

    eCOA solutions are transforming clinical trials by enabling accurate, real-time capture of patient, clinician, and caregiver-reported outcomes through smartphones, tablets, web portals, and provisioned devices. These platforms are redefining how clinical trials capture participant-reported data by…
  • Technology Awareness Deep Dive
    April 27, 2026

    Over the past decade, Cell and Gene Therapies (CGTs) have evolved significantly in terms of safety and efficacy, demonstrating their ability to rectify, replace, or reprogram diseased biology at its source. However, despite growing clinical validation…

Items per page